Announcements & Media Coverage

Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”)   Hemogenyx Pharmaceuticals Partnership with Selexis SA to Advance CDX Development Hemogenyx Pharmaceuticals and Selexis SA (“Selexis”) will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows to advance the Company’s acute myeloid leukemia CDX bispecific antibody toward human trials   Hemogenyx Pharmaceuticals plc (LSE:...